Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kisuma Chemicals is a global leader in the production of synthetic hydrotalcites and other specialty magnesium compounds. Based in the Netherlands and operating as a subsidiary of Kyowa Chemical Industry, the company provides high-purity materials for the pharmaceutical, plastics, and automotive industries. In the healthcare sector, Kisuma is a key supplier of active pharmaceutical ingredients (APIs) such as hydrotalcite and magnesium hydroxide, which are used extensively in antacid formulations. Their manufacturing facilities operate under strict quality standards, including GMP, to ensure the safety and efficacy of their pharmaceutical-grade products. The company is recognized for its innovation in hydrotalcite technology, offering specialized grades that serve as effective acid scavengers and stabilizers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kisuma Chemicals.